When will Raffles Medical report earnings and why does it matter for BSL.SI stock?

Raffles Medical reports on **18 Feb 2026**. The earnings matter because revenue mix, hospital margins and guidance will affect cash flow, dividend outlook and the BSL.SI stock reaction in the SES session.

What is Meyka AI's price forecast for BSL.SI stock and the implied upside?

Meyka AI's forecast model projects a yearly target of **S$1.09** versus the current **S$1.02**, implying about **+6.86%** upside. Forecasts are model-based projections and not guarantees.

What are the main valuation metrics to watch for BSL.SI stock?

Key metrics include PE **34.00**, PB **1.86**, P/S **2.46**, free cash flow yield about **5.20%**, and dividend yield **~2.45%**. These frame relative value in the Healthcare sector.

How does liquidity affect trading around the earnings for BSL.SI stock?

Current volume **221,800** is below average **1,423,060**, so liquidity is thin. Expect wider intraday swings and larger bid-ask impacts on earnings days in the SES market.

SG Stocks

Raffles Medical (BSL.SI, SES) S$1.02 intraday ahead of 18 Feb 2026 earnings: 1.09 forecast

ByHuzaifa Zahoor February 18, 2026February 18, 2026

The BSL.SI stock is trading at S$1.02 in the Singapore (SES) intraday session as investors position ahead of Raffles Medical Group Ltd’s earnings due 18 Feb 2026. Volume sits at 221,800 shares versus a 50-day average of 1,423,060. Key numbers to watch in the upcoming report include EPS S$0.03, PE 34.00, and margins. This earnings spotlight shows why near-term revenue mix, hospital admissions and China/Vietnam outpatient growth will drive the stock move.